Risk models constructed based on CAF-related genes, CDR2L, SPRED1, PFKP, ENG, KLF2, FSCN1 and VCAN were able to predict their association with prognosis, chemotherapy and immunotherapy response of HCC patients. This evidence concerns the gene CDR2L and hepatocellular carcinoma.